These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30444537)

  • 1. The effect of repeated stimulated granulocyte donations on hematopoietic indexes in donors: a 24-year donor center experience.
    Szymanski J; Troendle J; Leitman S; Hong H; Yau YY; Cantilena C
    Transfusion; 2019 Jan; 59(1):259-266. PubMed ID: 30444537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience.
    Quillen K; Yau YY; Leitman SF
    Transfusion; 2009 Mar; 49(3):421-6. PubMed ID: 19040597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eighteen years experience of granulocyte donations-acceptable donor safety?
    Axdorph Nygell U; Sollén-Nilsson A; Lundahl J
    J Clin Apher; 2015 Oct; 30(5):265-72. PubMed ID: 25546372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of G--CSF plus dexamethasone produces greater granulocyte concentrate yields while causing no more donor toxicity than G--CSF alone.
    Stroncek DF; Yau YY; Oblitas J; Leitman SF
    Transfusion; 2001 Aug; 41(8):1037-44. PubMed ID: 11493736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
    de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
    Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior blood donations do not affect efficacy of G-CSF mobilization nor outcomes of haematopoietic stem cell collection in healthy donors.
    Pruszczyk K; Bartnik K; Bogusz K; Farhan R; Cwil D; Jastrzębska A; Moskowicz A; Płachta M; Chmiel A; Skwierawska K; Urbanowska E; Jędrzejczak WW; Snarski E
    Vox Sang; 2019 Aug; 114(6):622-627. PubMed ID: 31168814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor.
    Chen J; Burns KM; Babic A; Carrum G; Kennedy M; Segura FJ; Garcia S; Potts S; Leveque C
    Transfusion; 2014 Jan; 54(1):203-10. PubMed ID: 23763340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
    Cavallaro AM; Lilleby K; Majolino I; Storb R; Appelbaum FR; Rowley SD; Bensinger WI
    Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone.
    Quillen K; Byrne P; Yau YY; Leitman SF
    Transfusion; 2009 Mar; 49(3):513-8. PubMed ID: 19243544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations.
    Panch SR; Logan B; Sees JA; Bo-Subait S; Savani B; Shah NN; Hsu JW; Switzer G; Lazarus HM; Anderlini P; Hematti P; Confer D; Pulsipher MA; Shaw BE; Stroncek DF
    Transplant Cell Ther; 2021 Jun; 27(6):503.e1-503.e8. PubMed ID: 33823169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study.
    Bertani G; Santoleri L; Martino M; Fedele R; Moscato T; Marenco P; Grillo G; Zucchetti E; Lotesoriere I; Lando G; Cesana C; Cairoli R; Rossini S
    Transfusion; 2014 Aug; 54(8):2028-33. PubMed ID: 24588265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenograstim with or without dexamethasone for neutrophil mobilization in healthy donors: short-term kinetics of white blood cells and effects of granulocyte apheresis.
    Kessler K; Goudeva L; Heuft HG
    J Clin Apher; 2011 Dec; 26(6):338-46. PubMed ID: 22072548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of granulocyte-colony-stimulating factor on potential normal granulocyte donors.
    McCullough J; Clay M; Herr G; Smith J; Stroncek D
    Transfusion; 1999 Oct; 39(10):1136-40. PubMed ID: 10532609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors].
    Zhang S; Jin H; Xu LP; Liu DH; Chen H; Liang YQ; Li T; Li FX; Wang R; Kang Q; Chen YH; Zhang XH; Han W; Huang XJ; Liu KY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1017-22. PubMed ID: 20723320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of hematocrit level for predicting the efficiency of peripheral blood CD34(+) cell collection after G-CSF Mobilization in Healthy Donors.
    Pornprasertsud N; Niparuck P; Kidkarn R; Puavilai T; Sirachainan N; Pakakasama S; Hongeng S; Jootar S; Ungkanont A
    J Clin Apher; 2015 Dec; 30(6):329-34. PubMed ID: 25663039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34
    Martino M; Gori M; Moscato T; Naso V; Ferreri A; Provenzano F; Loteta B; Sanguedolce MC; Console G; Dattola A; Pucci G; Gentile M; Morabito A; Recchia AG; Tripepi G; Pitino A
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1586-1591. PubMed ID: 31002994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells.
    Platzbecker U; Bornhäuser M; Zimmer K; Lerche L; Rutt C; Ehninger G; Hölig K
    Transfusion; 2005 Jan; 45(1):11-5. PubMed ID: 15647012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the mobilization regimen and the harvesting technique on the granulocyte yield in healthy donors for granulocyte transfusion therapy.
    Ikemoto J; Yoshihara S; Fujioka T; Ohtsuka Y; Fujita N; Kokubunji A; Okamoto N; Ono J; Taniguchi K; Kaida K; Ikegame K; Okada M; Tanizawa T; Ogawa H; Kai S
    Transfusion; 2012 Dec; 52(12):2646-52. PubMed ID: 22519863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.